![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 07, 2016 6:26:08 AM
Market is not stupid and if the execution and progress is right, the company/stock perform well.
We have seen many small biotechs came out of such attack and git bought or performed way better. Their CEOs (or investors) did not keep blaming shorts or article in one magazine.
List down actual progress where company has moved towards actual product approval in short term - 1 year and then see why there is no enthusiasm among investors
B-P3 - exactly after 2 years we still do not know when even 1st P3 will start
K - the wonderkid in blackbox - not sure when the real P2 on one indication will start (in last 2 years it just finished few cohorts and now has to prepare for actual trials)
B-OM - well 1 1/2 years - not even 36 patients enrolled
B-UP trial started - achievement
P - only bright spot - wait for next trial start
I know people will come with huge list of excuses and try to rip this off. But the summary is lack of progressed (trial not failing is partial achievement and it shows more of quality of drug they have not the quality of management)
So from market perspective - where is the excitement to invest in the company?
Leo's big achievement in 2016 is acknowledging that he cannot handle the company as effectively so bring external help in terms of Dr B.
Hope Dr B will make company more attractive.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM